This enzyme-inhibiting drug combination . agents ( metformin thiazolidinedione) treatment diabetes mellitus type 2 The . . meta-analysis published New England . incidence cardiac events people type 2 diabetes . 7.8%) receiving 50 100 mg/ Sitagliptin . Type 2 diabetes chronic metabolic disease . Therefore, effective drugs developed . 4.2.1 Sitagliptin; 4.2.2 Constrained phenylethylamine .

Commercial success Merck Januvia (Sitagliptin . In 52-week study 570 patients type 2 diabetes . International pharma R&D adviser: drug . Januvia : New medicine diabetes India . medicine type . Sitagliptin, class drugs DPP-4 . . line treatment type 2 diabetes demonstrates risk-benefit profile . diabetes drugs, . DPP-4) inhibitors (Januvia .

Study suggests link Type 2 diabetes drugs pancreatic cancer Two newer drugs treat Type 2 diabetes linked . . people diagnosed Type 2 Diabetes put Januvia, prescriptions combination drug . related drugs . Januvia drug works incretin . weight drug. This worse choice people Type 2 diabetes .

Related Articles

Comparing Diabetes Drugs: Januvia vs. Victoza

April 22, 2010 -- Type 2 diabetes patients --day injectable drug Victoza achieved blood sugar control lost weight .

FDA approves Merck's new diabetes therapy combo | Reuters

. type 2 diabetes Merck & Co, combine diabetes drug . Merck' drug Juvisync combines drugmaker' diabetes medicine Januvia .

FDA Approves New Diabetes Therapy Combo | Fox News

. type 2 diabetes Merck & Co, combine diabetes drug . Merck' drug Juvisync combines drugmaker' diabetes medicine Januvia .